Determination of Indoxyl Sulfate by Spectrofluorimetric Method in Human Plasma Through Extraction with Deep Eutectic Solvent

Overview

Journal BMC Chem

Publisher Springer Nature

Specialty Chemistry

Date 2024 Mar 30

PMID 38555438

Authors

Samira Shafiee

Siavoush Dastmalchi

Afshin Gharekhani

Ali Shayanfar

Affiliations

Soon will be listed here.

Abstract

A rapid and efficient analytical method was established to quantify indoxyl sulfate (IS) in plasma through extraction technique with a deep eutectic solvent (DES) and spectrofluorimetric method. DES (choline chloride: urea) was mixed with plasma samples for the extraction of IS, followed by the addition of dipotassium hydrogen phosphate (KHPO) solution to form an aqueous two-phase system. The fluorescence intensity of IS which was first extracted to the DES-rich-phase and then back-extracted into the salt-rich-phase, was measured by spectrofluorimetric method. Some key factors such as pH, centrifugation speed and time, the volume ratio of DES/salt, and salt concentration were optimized. Under the optimized conditions, the suggested method had a dynamic range between 20 and 160 µg/mL with a coefficient of determination (R) of 0.99. Precision (relative standard deviation) was less than 15% and accuracy (% relative recovery) was ± 15% at the nominal concentration level. In addition, results showed that IS levels in real samples were higher than 40 µg/mL which was compatible with reported IS levels in end-stage renal disease (ESRD) patients. Overall, all the results reflect the fact that the presented analytical method can potentially be used for the determination of IS in real plasma samples.

References

Summers S, Quimby J, Phillips R, Stockman J, Isaiah A, Lidbury J . Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p-cresol sulfate. J Vet Intern Med. 2019; 34(1):206-215. PMC: 6979089. DOI: 10.1111/jvim.15634. View

de Loor H, Meijers B, Meyer T, Bammens B, Verbeke K, Dehaen W . Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. J Chromatogr A. 2009; 1216(22):4684-8. DOI: 10.1016/j.chroma.2009.04.015. View

Saien J, Bahiraei M, Jafari F . A green hydrophobic deep eutectic solvent for extraction of phenol from aqueous phase. Sci Rep. 2023; 13(1):17449. PMC: 10576737. DOI: 10.1038/s41598-023-44600-x. View

Fujita K, Nonaka T, Kutsuno R, Ichida K . Electrochemical sensing of the secretion of indoxyl sulfate in a rat intestinal loop using a self-assembled monolayer-modified gold bead electrode. Talanta. 2022; 247:123551. DOI: 10.1016/j.talanta.2022.123551. View

Chiang C, Tanaka T, Inagi R, Fujita T, Nangaku M . Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Lab Invest. 2011; 91(11):1564-71. DOI: 10.1038/labinvest.2011.114. View

Caggiano G, Amodio L, Stasi A, Colabufo N, Colangiulo S, Pesce F . Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice. Int J Mol Sci. 2023; 24(6). PMC: 10049313. DOI: 10.3390/ijms24065142. View

Pretorius C, McWhinney B, Sipinkoski B, Johnson L, Rossi M, Campbell K . Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method. Clin Chim Acta. 2013; 419:122-6. DOI: 10.1016/j.cca.2013.02.008. View

Lu C, Zheng C, Lu K, Liao M, Wu K, Ma M . Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease. Antioxidants (Basel). 2021; 10(6). PMC: 8228088. DOI: 10.3390/antiox10060936. View

de Loor H, Poesen R, De Leger W, Dehaen W, Augustijns P, Evenepoel P . A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism. Anal Chim Acta. 2016; 936:149-56. DOI: 10.1016/j.aca.2016.06.057. View

10.

Shah P, Shrivastav P, Sharma V, Chavda V . Uncovering the green frontier: harnessing deep eutectic solvents for sustainable bioanalysis. Bioanalysis. 2023; 15(14):815-821. DOI: 10.4155/bio-2023-0088. View

11.

Hyspler R, Ticha A, Safranek R, Moucka P, Nyvltova Z, Stochlova K . Indoxyl Sulfate Elimination in Renal Replacement Therapy: Influence of Citrate- versus Acetate-Buffering Component during Bicarbonate Dialysis. Dis Markers. 2018; 2018:3985861. PMC: 6114072. DOI: 10.1155/2018/3985861. View

12.

Kanemitsu Y, Asaji K, Matsumoto Y, Tsukamoto H, Saigusa D, Mukawa C . Simultaneous quantitative analysis of uremic toxins by LC-MS/MS with a reversed-phase/cation-exchange/anion-exchange tri-modal mixed-mode column. J Chromatogr B Analyt Technol Biomed Life Sci. 2017; 1068-1069:1-8. DOI: 10.1016/j.jchromb.2017.10.009. View

13.

Lin C, Chen H, Pan C, Chuang C, Wang T, Sun F . p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J Clin Lab Anal. 2011; 25(3):191-7. PMC: 6647585. DOI: 10.1002/jcla.20456. View

14.

Giebultowicz J, Korytowska N, Sankowski B, Wroczynski P . Development and validation of a LC-MS/MS method for quantitative analysis of uraemic toxins p-cresol sulphate and indoxyl sulphate in saliva. Talanta. 2016; 150:593-8. DOI: 10.1016/j.talanta.2015.12.075. View

15.

Rajasekaran R, Aruna P, Koteeswaran D, Bharanidharan G, Baludavid M, Ganesan S . Steady-state and time-resolved fluorescence spectroscopic characterization of urine of healthy subjects and cervical cancer patients. J Biomed Opt. 2014; 19(3):37003. DOI: 10.1117/1.JBO.19.3.037003. View

16.

Fan P, Chang J, Lin C, Lee C, Chen Y, Chu P . Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease. J Formos Med Assoc. 2019; 118(7):1099-1106. DOI: 10.1016/j.jfma.2019.03.005. View

17.

Lisowska-Myjak B . Uremic toxins and their effects on multiple organ systems. Nephron Clin Pract. 2014; 128(3-4):303-11. DOI: 10.1159/000369817. View

18.

Wu C, Chen C, Lai T, Wu P, Chuang C, Sun F . Correction: The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease. Oncotarget. 2019; 10(20):2006. PMC: 6443016. DOI: 10.18632/oncotarget.26782. View

19.

Cheng F, Hsieh M, Chou C, Hsu W, Lee Y . Detection of indoxyl sulfate levels in dogs and cats suffering from naturally occurring kidney diseases. Vet J. 2015; 205(3):399-403. DOI: 10.1016/j.tvjl.2015.04.017. View

20.

Choi J, Park W, Song K, Lee H, Jung B . Development of simultaneous analysis of tryptophan metabolites in serum and gastric juice - an investigation towards establishing a biomarker test for gastric cancer diagnosis. Biomed Chromatogr. 2016; 30(12):1963-1974. DOI: 10.1002/bmc.3773. View